BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 24446063)

  • 21. Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial.
    Salib M; Girerd S; Girerd N; März W; Scharnagl H; Massy ZA; Leroy C; Duarte K; Holdaas H; Jardine AG; Schmieder RE; Fellström B; López-Andrés N; Rossignol P; Zannad F
    Clin Res Cardiol; 2022 Jun; 111(6):614-626. PubMed ID: 34170371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
    Sweeney M; Corden B; Cook SA
    EMBO Mol Med; 2020 Oct; 12(10):e10865. PubMed ID: 32955172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Range of adiposity and cardiorenal syndrome.
    Pazos F
    World J Diabetes; 2020 Aug; 11(8):322-350. PubMed ID: 32864046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease.
    Packer M; Lam CSP; Lund LH; Maurer MS; Borlaug BA
    Eur J Heart Fail; 2020 Sep; 22(9):1551-1567. PubMed ID: 32441863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-fat diet induced central adiposity (visceral fat) is associated with increased fibrosis and decreased immune cellularity of the mesenteric lymph node in mice.
    Magnuson AM; Regan DP; Booth AD; Fouts JK; Solt CM; Hill JL; Dow SW; Foster MT
    Eur J Nutr; 2020 Jun; 59(4):1641-1654. PubMed ID: 31165249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation.
    Barchetta I; Cimini FA; Ciccarelli G; Baroni MG; Cavallo MG
    J Endocrinol Invest; 2019 Nov; 42(11):1257-1272. PubMed ID: 31073969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Echocardiographic diastolic function evolution in patients with an anterior Q-wave myocardial infarction: insights from the REVE-2 study.
    Ferreira JP; Bauters C; Eschalier R; Lamiral Z; Fay R; Huttin O; Girerd N; Zannad F; Pinet F; Rossignol P
    ESC Heart Fail; 2019 Feb; 6(1):70-79. PubMed ID: 30460754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between Cardiac Remodeling and Metabolic Alteration in an Experimental Model of Obesity Induced by Western Diet.
    Ferron AJT; Francisqueti FV; Minatel IO; Silva CCVA; Bazan SGZ; Kitawara KAH; Garcia JL; Corrêa CR; Moreto F; Ferreira ALA
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity and metabolic features associated with long-term developing diastolic dysfunction in an initially healthy population-based cohort.
    Chau K; Girerd N; Magnusson M; Lamiral Z; Bozec E; Merckle L; Leosdottir M; Bachus E; Frikha Z; Ferreira JP; Després JP; Rossignol P; Boivin JM; Zannad F
    Clin Res Cardiol; 2018 Oct; 107(10):887-896. PubMed ID: 29680861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of oxidative stress in the crosstalk between leptin and mineralocorticoid receptor in the cardiac fibrosis associated with obesity.
    Gutiérrez-Tenorio J; Marín-Royo G; Martínez-Martínez E; Martín R; Miana M; López-Andrés N; Jurado-López R; Gallardo I; Luaces M; San Román JA; González-Amor M; Salaices M; Nieto ML; Cachofeiro V
    Sci Rep; 2017 Dec; 7(1):16802. PubMed ID: 29196758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic acid prevents cardiac dysfunction and reduces myocardial fibrosis in a mouse model of high-fat diet-induced obesity.
    Li W; Tang R; Ouyang S; Ma F; Liu Z; Wu J
    Nutr Metab (Lond); 2017; 14():68. PubMed ID: 29118818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editorial: Cardiac Remodeling: New Insights in Physiological and Pathological Adaptations.
    Roever L; Palandri Chagas AC
    Front Physiol; 2017; 8():751. PubMed ID: 29018366
    [No Abstract]   [Full Text] [Related]  

  • 33. MicroRNA-9 inhibits high glucose-induced proliferation, differentiation and collagen accumulation of cardiac fibroblasts by down-regulation of TGFBR2.
    Li J; Dai Y; Su Z; Wei G
    Biosci Rep; 2016 Dec; 36(6):. PubMed ID: 27756824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abdominal obesity and hypertension: a double burden to the heart.
    Krzesiński P; Stańczyk A; Piotrowicz K; Gielerak G; Uziębło-Zyczkowska B; Skrobowski A
    Hypertens Res; 2016 May; 39(5):349-55. PubMed ID: 26791010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left Ventricular Hypertrophy and Asymptomatic Cardiac Function Impairment in Chinese Patients with Simple Obesity using Echocardiography.
    Sun T; Xie J; Zhu L; Han Z; Xie Y
    Obes Facts; 2015; 8(3):210-9. PubMed ID: 26087902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiospecific CD36 suppression by lentivirus-mediated RNA interference prevents cardiac hypertrophy and systolic dysfunction in high-fat-diet induced obese mice.
    Zhang Y; Bao M; Dai M; Wang X; He W; Tan T; Lin D; Wang W; Wen Y; Zhang R
    Cardiovasc Diabetol; 2015 Jun; 14():69. PubMed ID: 26036798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators.
    Buglioni A; Burnett JC
    Clin Chim Acta; 2015 Mar; 443():3-8. PubMed ID: 25445413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities.
    Cavalera M; Wang J; Frangogiannis NG
    Transl Res; 2014 Oct; 164(4):323-35. PubMed ID: 24880146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Features of cardiac remodeling, associated with blood pressure and fibrosis biomarkers, are frequent in subjects with abdominal obesity.
    Eschalier R; Rossignol P; Kearney-Schwartz A; Adamopoulos C; Karatzidou K; Fay R; Mandry D; Marie PY; Zannad F
    Hypertension; 2014 Apr; 63(4):740-6. PubMed ID: 24446063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives.
    Pastormerlo LE; Maffei S; Latta DD; Chubuchny V; Susini C; Berti S; Clerico A; Prontera C; Passino C; Januzzi JL; Emdin M; Chiappino D
    Eur J Prev Cardiol; 2016 Mar; 23(4):366-76. PubMed ID: 25644699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.